These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20231300)

  • 1. Does adjuvant fluoropyrimidine-based chemotherapy provide a benefit for patients with resected rectal cancer who have already received neoadjuvant radiochemotherapy? A systematic review of randomised trials.
    Bujko K; Glynne-Jones R; Bujko M
    Ann Oncol; 2010 Sep; 21(9):1743-1750. PubMed ID: 20231300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery ± a fluoropyrimidine and surgery + a fluoropyrimidine ± oxaliplatin.
    Bujko K; Glimelius B; Valentini V; Michalski W; Spalek M
    Eur J Surg Oncol; 2015 Jun; 41(6):713-23. PubMed ID: 25911110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant Chemotherapy in Rectal Cancer after Chemoradiotherapy.
    Boustani J; Caubet M; Bosset JF
    Clin Oncol (R Coll Radiol); 2016 Feb; 28(2):140-145. PubMed ID: 26698026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data.
    Breugom AJ; Swets M; Bosset JF; Collette L; Sainato A; Cionini L; Glynne-Jones R; Counsell N; Bastiaannet E; van den Broek CB; Liefers GJ; Putter H; van de Velde CJ
    Lancet Oncol; 2015 Feb; 16(2):200-7. PubMed ID: 25589192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer.
    Sastre J; Custodio A; Sanchez JC; Ortega L; Rodriguez L; Puente J; Corona J; Alfonso R; de las Heras M; Dıaz-Rubio E
    Anticancer Drugs; 2011 Feb; 22(2):185-90. PubMed ID: 21218606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic overview of chemotherapy effects in colorectal cancer.
    Ragnhammar P; Hafström L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):282-308. PubMed ID: 11441937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies].
    Créhange G; Bosset JF; Maingon P
    Cancer Radiother; 2011 Oct; 15(6-7):440-4. PubMed ID: 21802334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial.
    Hong YS; Nam BH; Kim KP; Kim JE; Park SJ; Park YS; Park JO; Kim SY; Kim TY; Kim JH; Ahn JB; Lim SB; Yu CS; Kim JC; Yun SH; Kim JH; Park JH; Park HC; Jung KH; Kim TW
    Lancet Oncol; 2014 Oct; 15(11):1245-53. PubMed ID: 25201358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy after neoadjuvant chemo-radiotherapy and surgery in locally advanced rectal cancer. A systematic review of literature with a meta-analysis of randomized clinical trials.
    Tamburini E; Tassinari D; Ramundo M; De Stefano A; Viola MG; Romano C; Elia MT; Zanaletti N; Rudnas B; Casadei-Gardini A; Delrio P; Toma I; Granata V; Petrucelli L; Avallone A
    Crit Rev Oncol Hematol; 2022 Apr; 172():103627. PubMed ID: 35202817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Practical neoadjuvant and adjuvant therapies for rectal cancer. How many patients are actually recruited in multimodality therapy concepts? An analysis of the Tumour Centre Schwerin].
    Sauer J; Sobolewski K; Dommisch K
    Zentralbl Chir; 2009 Sep; 134(5):450-4. PubMed ID: 19757345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.
    Collette L; Bosset JF; den Dulk M; Nguyen F; Mineur L; Maingon P; Radosevic-Jelic L; Piérart M; Calais G;
    J Clin Oncol; 2007 Oct; 25(28):4379-86. PubMed ID: 17906203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer : is it time for a randomized phase III trial?
    Rödel C; Arnold D; Becker H; Fietkau R; Ghadimi M; Graeven U; Hess C; Hofheinz R; Hohenberger W; Post S; Raab R; Sauer R; Wenz F; Liersch T
    Strahlenther Onkol; 2010 Dec; 186(12):658-64. PubMed ID: 21136027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neoadjuvant and adjuvant radiochemotherapy for rectal carcinoma].
    Seegenschmiedt MH
    MMW Fortschr Med; 2007 Jun; 149(23):33-5. PubMed ID: 18062575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.
    Zhao L; Liu R; Zhang Z; Li T; Li F; Liu H; Li G
    Colorectal Dis; 2016 Aug; 18(8):763-72. PubMed ID: 27169752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
    Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
    Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial: implication for subsequent local excision.
    Bujko K; Nowacki MP; Nasierowska-Guttmejer A; Kepka L; Winkler-Spytkowska B; Suwiński R; Oledzki J; Stryczyńska G; Wieczorek A; Serkies K; Rogowska D; Tokar P;
    Radiother Oncol; 2005 Sep; 76(3):234-40. PubMed ID: 16273666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adjuvant and neoadjuvant radiochemotherapy of rectal carcinoma].
    Sauer R; Rödel C
    Praxis (Bern 1994); 2002 Sep; 91(37):1476-84. PubMed ID: 12360683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and future directions in adjuvant combined-modality therapy of rectal cancer.
    Minsky BD
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):61-8. PubMed ID: 9348572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cetuximab and chemoradiation for rectal cancer--is the water getting muddy?
    Glynne-Jones R; Mawdsley S; Harrison M
    Acta Oncol; 2010 Apr; 49(3):278-86. PubMed ID: 20180626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.